✦ LIBER ✦

SNS 595 promising for platinum-resistant ovarian cancer

Book ID: 120844183
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2008
Weight: 133 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200816290-00020

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Alvocidib + cisplatin promising for plat

Alvocidib + cisplatin promising for platinum-resistant ovarian cancer

📂 Article 📅 2007 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

Platinum-Resistant and Refractory Ovaria

Platinum-Resistant and Refractory Ovarian Cancer

✍ Dr Angeles A. Alvarez, Daniel L. Clarke-Pearson 📂 Article 📅 2003 🏛 Adis International Limited (now part of Wolters Kl 🌐 English ⚖ 136 KB

Weekly topotecan for recurrent platinum

Weekly topotecan for recurrent platinum resistant ovarian cancer

✍ Fadi Abushahin; Diljeet K. Singh; John R. Lurain; Edward C. Grendys; Alfred W. R 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 133 KB

Weekly paclitaxel effective for platinum

Weekly paclitaxel effective for platinum-resistant ovarian cancer

📂 Article 📅 2006 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

Management Strategies for Recurrent Plat

Management Strategies for Recurrent Platinum-Resistant Ovarian Cancer

✍ Dr R. Wendel Naumann, Robert L. Coleman 📂 Article 📅 2011 🏛 Springer International Publishing AG 🌐 English ⚖ 181 KB

Molecular profiling of platinum resistan

Molecular profiling of platinum resistant ovarian cancer

✍ Jozien Helleman; Maurice P.H.M. Jansen; Paul N. Span; Iris L. van Staveren; Leon 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 362 KB

## Abstract The aim of this study is to discover a gene set that can predict resistance to platinum‐based chemotherapy in ovarian cancer. The study was performed on 96 primary ovarian adenocarcinoma specimens from 2 hospitals all treated with platinum‐based chemotherapy. In our search for genes, 24